Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Take-Two Interactive Software, Inc. (TTWO) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Take-Two Interactive Software, Inc. (TTWO) - free report >>
Portfolio Rundown: Q3 Earnings Overview
The news seems to be coming to a slow crawl and earnings have taken completely over. We run down a few of the top earnings reports including Square Inc (SQ - Free Report) , Disney (DIS - Free Report) and Take-Two Interactive (TTWO - Free Report) . Some of these earnings directly effect our paper trading portfolios so we dive in and see how exactly we have been impacted. With market continuing to hit all time highs we could be poised to see some big winners! To get recent Zacks video updates, be sure to subscribe to our Youtube channel and participate by leaving any comments or questions.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>